Diarrheagenic Escherichia coli
JP Nataro, JB Kaper - Clinical microbiology reviews, 1998 - Am Soc Microbiol
Escherichia coli is the predominant nonpathogenic facultative flora of the human intestine.
Some E. coli strains, however, have developed the ability to cause disease of the …
Some E. coli strains, however, have developed the ability to cause disease of the …
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
PI Tarr, CA Gordon, WL Chandler - The lancet, 2005 - thelancet.com
Most cases of diarrhoea-associated haemolytic uraemic syndrome (HUS) are caused by
Shiga-toxin-producing bacteria; the pathophysiology differs from that of thrombotic …
Shiga-toxin-producing bacteria; the pathophysiology differs from that of thrombotic …
[PDF][PDF] The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome
PM Griffin, RV Tauxe - Epidemiologic reviews, 1991 - academia.edu
In 1982, investigation of two outbreaks of a distinctive bloody diarrheal syndrome led to the
identification of a new bacterial pathogen, Escherichia coli O157: H7 (1). In the decade …
identification of a new bacterial pathogen, Escherichia coli O157: H7 (1). In the decade …
Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
Since their initial recognition 20 years ago, Shiga toxin-producing Escherichia coli (STEC)
strains have emerged as an important cause of serious human gastrointestinal disease …
strains have emerged as an important cause of serious human gastrointestinal disease …
Practice guidelines for the management of infectious diarrhea
RL Guerrant, T Van Gilder, TS Steiner… - Clinical infectious …, 2001 - academic.oup.com
The widening array of recognized enteric pathogens and the increasing demand for cost-
containment sharpen the need for careful clinical and public health guidelines based on the …
containment sharpen the need for careful clinical and public health guidelines based on the …
The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections
Background Children with gastrointestinal infections caused by Escherichia coli O157: H7
are at risk for the hemolytic–uremic syndrome. Whether antibiotics alter this risk is unknown …
are at risk for the hemolytic–uremic syndrome. Whether antibiotics alter this risk is unknown …
Escherichia coli O157: H7
PS Mead, PM Griffin - The Lancet, 1998 - thelancet.com
Escherichia coli O157 was first identified as a human pathogen in 1982. One of several
Shiga toxin-producing serotypes known to cause human illness, the organism probably …
Shiga toxin-producing serotypes known to cause human illness, the organism probably …
Shiga Toxin–Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis
SB Freedman, J Xie, MS Neufeld… - Clinical Infectious …, 2016 - academic.oup.com
Background. Antibiotic administration to individuals with Shiga toxin–producing Escherichia
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …
Bacteriophage control of bacterial virulence
PL Wagner, MK Waldor - Infection and immunity, 2002 - Am Soc Microbiol
In 1930, Felix d'Herelle wrote “... the actions and reactions are not solely between these two
beings, man and bacterium, for the bacteriophage also intervenes; a third living being and …
beings, man and bacterium, for the bacteriophage also intervenes; a third living being and …
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice
X Zhang, AD McDaniel, LE Wolf… - The Journal of …, 2000 - academic.oup.com
Shiga toxin-producing Escherichia coli (STEC) cause significant disease; treatment is
supportive and antibiotic use is controversial. Ciprofloxacin but not fosfomycin causes Shiga …
supportive and antibiotic use is controversial. Ciprofloxacin but not fosfomycin causes Shiga …